Document is current
Any future updates will be listed below
-
Authors
Andelova, Michaela https://orcid.org/0000-0002-3812-7483
Vodehnalova, Karolina
Krasensky, Jan
Hardubejova, Eliska
Hrnciarova, Tereza
Srpova, Barbora
Uher, Tomas
Menkyova, Ingrid
Stastna, Dominika
Friedova, Lucie
Motyl, Jiri
Lizrova Preiningerova, Jana
Kubala Havrdova, Eva
Maréchal, Bénédicte
Fartaria, Mário João
Kober, Tobias
Horakova, Dana
Vaneckova, Manuela
-
Funding
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (NV18-04-00168)
Roche
Hospital Research Foundation (RVO VFN 64165)
Ministerstvo Školství, Mládeže a Tělovýchovy (Cooperatio LF1, Cooperatio LF1 and by the National Institute for Neurological Research (Programme EXCELES, ID project No LX22NPO5107)- funded by the European Union-Next Generation EU)
- License Information
-
More Information
Article History
Received: 27 May 2021
Accepted: 29 June 2022
First Online: 19 July 2022
Declarations
:
: The study was conducted according to the Declaration of Helsinki and The <i>Ethics Committee</i> of the <i>General Teaching Hospital</i> in Prague (Chairperson - Josef Sedivy, MD) provided approval for the examination of both MS patients and for healthy individuals. (Number: NV18–04-00168 01.5.2018–31.12.2021).Each participant involved in this study provided a written informed consent before collecting, storing and analysing individual data.
: Not applicable.
: The authors declare that they have no competing interests.
